Search This Blog

Wednesday, June 19, 2019

Mirati downgraded, target hiked at B. Riley

B. Riley FBR has downgraded Mirati Therapeutics Inc from buy to neutral, raising its price target from $ 60 to $ 92.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)